Literature DB >> 2174707

Extended hepatectomy for hepatocellular carcinoma.

S al-Hadeedi1, T K Choi, J Wong.   

Abstract

The results of extended hepatectomy in 25 patients with hepatocellular carcinoma performed over a 16 year period have been reviewed, analysed and compared with those of 144 patients who underwent lesser liver resection. Five left and 20 right extended hepatectomies were performed for tumours ranging from 3 to 20 cm in diameter. Seventeen (68 per cent) of the patients had non-cirrhotic livers. The major postoperative complications were: haemorrhage in five cases, major bile duct injury in three, subphrenic abscess in two, liver failure in one and wound dehiscence in one. The 30-day (operative) mortality rate was 12 per cent and the median survival duration, including operative mortality, was 9.7 (range 0.2-32.1) months. The survival rate was 46 per cent at 1 year, 33 per cent at 2 years and 22 per cent at 3 years. The morbidity, mortality and survival data of extended hepatectomy were comparable with the results of lesser hepatic resections for hepatocellular carcinoma. We conclude that extended hepatectomy is a worthwhile operation for large hepatocellular carcinomas and a viable alternative to liver transplantation.

Entities:  

Mesh:

Year:  1990        PMID: 2174707     DOI: 10.1002/bjs.1800771116

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

Review 2.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

3.  Liver trisectionectomies for primary and secondary liver cancer in the modern era: results of a single tertiary center.

Authors:  Nadia Russolillo; Alessandro Ferrero; Luca Viganò; Serena Langella; Marco Amisano; Lorenzo Capussotti
Journal:  Updates Surg       Date:  2010-12-16

4.  Pretreatment with enteral cholestyramine prevents suppression of the cellular immune system after partial hepatectomy.

Authors:  P A Van Leeuwen; M A Boermeester; A P Houdijk; S Meyer; M A Cuesta; R I Wesdorp; M L Rodrick; D W Wilmore
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

5.  Hepatocellular carcinoma with adjacent organ extension: the enhancement of preoperative transcatheter arterial embolization and the results of surgical resection.

Authors:  C C Wu; W L Ho; T J Liu
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 6.  [Liver resections for primary liver malignancies. Personal results and analysis of the literature].

Authors:  J Zieren; H U Zieren; J M Müller
Journal:  Langenbecks Arch Chir       Date:  1994

7.  En bloc resection for extensive hepatocellular carcinoma: is it advisable?

Authors:  K S Jeng; B F Chen; H J Lin
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

8.  Mesohepatectomy for hepatocellular carcinoma: a study of 256 patients.

Authors:  Xiao-Ping Chen; Fa-Zu Qiu; Wan-Yee Lau; Bi-Xiang Zhang; Yi-Fa Chen; Wan-Guang Zhang; Song-Qing He
Journal:  Int J Colorectal Dis       Date:  2008-01-09       Impact factor: 2.571

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.